Gottenberg, Jacques-Eric

Effect of Tocilizumab vs Usual Care in Adults Hospitalized With COVID-19 and Moderate or Severe Pneumonia: A Randomized Clinical Trial

Hermine, O., Mariette, X., Tharaux, P.-L., Resche-Rigon, M., Porcher, R., Ravaud, P., CORIMUNO-19 Collaborative Group, Bureau, S., Dougados, M., Tibi, A., et al. (2021) · JAMA Internal Medicine

COVID-19 Clinical Research StudiesRespiratory Support and Mechanisms

Cited by 734

EULAR recommendations for the management of Sjogren's syndrome with topical and systemic therapies

Ramos-Casals, M., Brito-Zerón, P., Bombardieri, S., Bootsma, H., De Vita, S., Dörner, T., Fisher, B. A., Gottenberg, J.-E., Hernandez-Molina, G., Kocher, A., et al. (2020) · Annals of the Rheumatic Diseases

Salivary Gland Disorders and FunctionsOcular Surface and Contact Lens

Cited by 732

Treatment of Primary Sjögren Syndrome With Rituximab: A Randomized Trial

Devauchelle-Pensec, V., Mariette, X., Jousse-Joulin, S., Berthelot, J.-M., Perdriger, A., Puéchal, X., Le Guern, V., Sibilia, J., Gottenberg, J.-E., Chiche, L., et al. (2014) · Annals of Internal Medicine

Salivary Gland Disorders and FunctionsOcular Surface and Contact Lens

Cited by 429

B lymphocytes and B-cell activating factor promote collagen and profibrotic markers expression by dermal fibroblasts in systemic sclerosis

François, A., Chatelus, E., Wachsmann, D., Sibilia, J., Bahram, S., Alsaleh, G., & Gottenberg, J.-E. (2013) · Arthritis Research & Therapy

Systemic Sclerosis and Related DiseasesDupuytren's Contracture and Treatments

Cited by 149

Continuing versus tapering glucocorticoids after achievement of low disease activity or remission in rheumatoid arthritis (SEMIRA): a double-blind, multicentre, randomised controlled trial

Burmester, G. R., Buttgereit, F., Bernasconi, C., Álvaro-Gracia, J. M., Castro, N., Dougados, M., Gabay, C., van Laar, J. M., Nebesky, J. M., Pethoe-Schramm, A., et al. (2020) · The Lancet

Rheumatoid Arthritis Research and TherapiesAutoimmune and Inflammatory Disorders Research

Cited by 128

B cell activating factor is central to bleomycin- and IL-17-mediated experimental pulmonary fibrosis

François, A., Gombault, A., Villeret, B., Alsaleh, G., Fanny, M., Gasse, P., Adam, S. M., Crestani, B., Sibilia, J., Schneider, P., et al. (2015) · Journal of Autoimmunity

Interstitial Lung Diseases and Idiopathic Pulmonary FibrosisTransplantation: Methods and Outcomes

Cited by 109

Effect of SARS-CoV-2 Vaccination on Symptoms from Post-Acute Sequelae of COVID-19: Results from the Nationwide VAXILONG Study

Scherlinger, M., Pijnenburg, L., Chatelus, E., Arnaud, L., Gottenberg, J.-E., Sibilia, J., & Felten, R. (2021) · Vaccines

Long-Term Effects of COVID-19SARS-CoV-2 and COVID-19 Research

Cited by 45

Response to biologic drugs in patients with rheumatoid arthritis and antidrug antibodies

Bitoun, S., Hässler, S., Ternant, D., Szely, N., Gleizes, A., Richez, C., Soubrier, M., Avouac, J., Brocq, O., Sellam, J., et al. (2023) · JAMA Network Open

Rheumatoid Arthritis Research and TherapiesBiosimilars and Bioanalytical Methods

Cited by 43